Concentra Group Holdings Parent, Inc. · Specialty Outpatient Facilities, NEC

CON

Low riskNext report: Around Nov 5 (est.)

View price ↗

The short version

A profitable company with growing sales. Institutions are adding.

Going well

Sales up 10% in the latest quarter vs a year ago
Profitable
Sales up 14% last year

Watch out for

Share count growing 7.3% a year
High debt: 3.98x equity

Money moves

No insider buying or selling in the last 30 days
Institutions added 4.2% to their holdings in the quarter ending June 2026 (161 bought, 122 sold)

Facts from SEC filings, not a recommendation.

What the price means

Price as of Oct 26

$40.22+2.4% that day

Company value: $5.1B; Share price times all shares
Price vs profit (P/E): 25.9x; You pay about $26 for each $1 of yearly profit
Price vs sales: 2.2x; Company value is 2.2 times a year of sales
Dividend yield: 0.6%; Yearly dividend as a share of today's price
Cash vs value: 3%; Cash as a share of company value
Debt vs value: 30%; Debt as a share of company value

From CON's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.

The business over time

Last 12 quarters, from SEC filings

Sales, Jun '26

$606.0M+10% vs a year earlier

Sep '23Tap a barJun '26

Last 12 months: $2.3B, up 14% from the 12 months before.

What the price assumes

Your guesses, our math

Move the sliders to your own view of CON. Starting points are the company's recent numbers.

Sales growth+14% a yearRecently: +14% a yearProfit margin9%Last 12 months: 8.7%P/E at the end26xToday: 25.9x. Many steady companies trade at 12x to 25xShare count change+8% a yearBelow zero means buybacks; above zero means new shares (dilution)

Sales in 5 years$4.4B

Profit in 5 years$396M

Price these guesses point to$55.01+37% vs $40.22 todayAbout +6.5% a year, before dividends

What today's price needs: with a 9% margin and a 26x P/E, sales would have to grow about 7.1% a year for 5 years just to match today's price.

Simple math on your guesses, not a forecast or a price target. Real results depend on many things these sliders leave out.

Price

Price chart by TradingView.

Business quality

The checklist Warren Buffett-style investors use. Annual numbers for 2025.

2/5Weak

PassReturn on equity 15%+Earns a lot on the money owners have in the business.49.8%
MissDebt under half of equityNot relying on borrowed money.3.98x equity
MissNet margin 10%+Keeps at least 10 cents of profit from each dollar of sales.7.7%
PassFree cash flow positiveBrings in more cash than it spends to run and grow.$197.1M
MissShare count not growingNot diluting owners. Falling means buybacks.+23.6% in 3 years

Revenue: $2.2B; +13.9% vs prior year
Total debt: $1.6B; 3.98x equity
Current ratio: 1.14x; short-term assets / bills due
Free cash flow: $197.1M; 9.1% of revenue

From annual reports filed with the SEC. Not in this company's SEC data, so not scored: profitable every year, gross margin 40%+. A checklist is a starting point for research, not a verdict.